All Articles

New patient-journey research suggests AI is speeding up health research rather than settling it. The opportunity for providers is to become the place patients use to verify and act.

UK shoppers may belong to an average of 12 loyalty schemes, but new evidence suggests everyday brand habit is weakening. The priority is useful repeat choice, not larger member files.

A new nationally representative B2B model is a useful advance. Its greater contribution may be to force sharper choices about whether research represents firms, roles or buying groups.

New UK shopper research puts a number on a familiar store frustration. Retailers should treat help-seeking, delay and recovery as demand signals, not staffing anecdotes.

New analysis of multi-market campaigns suggests international scale can build brand effects while weakening commercial impact when adaptation turns into creative caution.

Boots’ work with DAIVID and CreativeX shows why creative effectiveness is moving beyond campaign evaluation towards a more useful question: which assets deserve the next pound of media spend?

B2B market research helps organisations understand professional buyers, users and markets. This guide explains the methods, process and practical decisions involved.

A new B2B buyer study finds high satisfaction alongside widespread willingness to review suppliers. Insight teams need to measure the comparison process, not satisfaction alone.

New UK research suggests discount shopping is becoming an active preference rather than a reluctant compromise. That raises the standard for every retailer charging more.

Newsworks’ new sales modelling gives cultural relevance welcome commercial weight. But brands will get more from treating it as a diagnostic than another headline KPI.

PwC’s latest regional reading suggests a sharper recovery in West Midlands consumer confidence than elsewhere. But higher intent to spend is not a licence for blunt festive retailing.

New patient research in chronic kidney disease exposes a wide gap between lived symptoms and clinical chart labels. The answer is not more data alone, but better symptom conversations.

New advertising research suggests perseverance-themed creative can prompt consumers to explore and switch. That makes it a useful, but narrowly targeted, trial device.

YouGov’s expansion of AI-moderated interviews makes qualitative evidence faster to access. It also raises the standard for traceability, challenge and human judgement.

Ofcom’s new behavioural audit shows that live platforms make engagement immediate and protection peripheral. That is a product-design problem with commercial consequences.

New Ipsos findings show technology anxiety at a long-term high in Britain. For brands, AI adoption now depends as much on perceived control and proof as capability.

New IPA evidence shows commercial media is increasingly consumed alone. Brands now need to distinguish between personal relevance and the rarer power of shared attention.

Ipsos’s latest work on digital twins points to a useful role in early innovation screening. But the research industry needs to define where simulation ends and evidence begins.

A new UK capability study shows retail media’s data promise is real. Its next commercial test is whether brands can compare results across networks with confidence.

From global research groups to agile specialists, these five UK market research companies offer distinctly different strengths for B2B insight projects.